tiprankstipranks

Analyst Profile

Followed by 249 followers
.
Sean Lee CFA

Sean Lee CFA

H.C. Wainwright
Wall Street Analyst
#7,744 out of 7,963 Wall Street Analysts
#21,605 out of 22,261 experts

Success Rate

16%
16 out of 97 transactions made a profit

Average Return

-22.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Sean Lee CFA's trades since 2021 and holding each position for 1 Year would result in 16.49% of your transactions generating a profit, with an average return of -22.9% per rating.

Stock Rating Distribution

111Ratings
97.30% Buy
2.70% Hold
0.00% Sell
Distribution of Sean Lee CFA's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market
GermanyGermany Market

Best Rating

Stock:
Alphatec
(ATEC)
Rating:Buy
Date:Apr 09, 2020 - Apr 09, 2021
Return:+346.70%
The most profitable rating made by Sean Lee CFA

Sean Lee CFA's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Idera
Mar 19, 2021
Hold
Downgraded
6Ratings
20%
-11.38%
OSE Immunotherapeutics SA
Oct 14, 2021
Buy
Reiterated
2Ratings
0.00%
Kazia Therapeutics
Aug 02, 2022
Hold
Downgraded
5Ratings
0%
-38.90%
Alphatec Holdings
Aug 05, 2022
Buy
Reiterated
$20.00
(129.62% Upside)
15Ratings
38%
+40.98%
ThermoGenesis Holdings
Aug 12, 2022
Buy
Reiterated
$1.00
(325.53% Upside)
9Ratings
0%
-59.90%
Monopar Therapeutics Inc
Aug 16, 2022
Buy
Reiterated
$6.00
(297.35% Upside)
6Ratings
0%
-40.58%
Plus Therapeutics
Sep 07, 2022
Buy
Reiterated
$3.50
(629.17% Upside)
9Ratings
0%
-49.44%
Gritstone Oncology
Sep 12, 2022
Buy
Reiterated
$12.00
(374.31% Upside)
14Ratings
36%
+5.62%
Virios Therapeutics
Sep 20, 2022
Hold
Downgraded
6Ratings
0%
-90.70%
Cytosorbents
Sep 28, 2022
Buy
Reiterated
$9.00
(581.82% Upside)
13Ratings
9%
-36.40%
List of latest recommendations made by Sean Lee CFA. Click to expand and see Sean Lee CFA's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >